The pharmacogenomics study of acute myelogenous leukemia

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-PPC-14005297

Enrollment

Unknown

Registered

2014-09-30

Start date

2010-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukemia

Interventions

No :No

Eligibility

Age

14 Years to 72 Years

Inclusion criteria

Inclusion criteria: Acute myelogenous leukemia patients

Exclusion criteria

Exclusion criteria: Non-acute myelogenous leukemia patients

Design outcomes

Primary

Measure	Time frame
CR rates;Overall survival;Relapse-free survival;	—

Secondary

Measure	Time frame
Gene expression;	—

Countries

China

Contacts

Public ContactXiao-Ping Chen

chenxp74@hotmail.com+86 13875803018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026